183 related articles for article (PubMed ID: 35418287)
1. COVID-19 Mortality in Patients with Rheumatic Diseases: A Real Concern.
Al-Adhoubi NK; Ali M; Wahshi HA; Salmi IA; Al-Balushi F; Lawati TA; Mohammed A; Muqbali AA; Kalbani HA; Al-Abrawi S; Khamis F
Curr Rheumatol Rev; 2022; 18(3):234-242. PubMed ID: 35418287
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A
J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163
[TBL] [Abstract][Full Text] [Related]
3. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
4. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Gonzalez-Gonzalez V; Beltran-Aguilar VM; Arias-Peralta AG; De Avila-Gonzalez N; Guajardo-Jauregui N
Clin Rheumatol; 2023 Oct; 42(10):2677-2690. PubMed ID: 36627529
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
Bakasis AD; Mavragani CP; Boki KA; Tzioufas AG; Vlachoyiannopoulos PG; Stergiou IE; Skopouli FN; Moutsopoulos HM
J Autoimmun; 2021 Sep; 123():102687. PubMed ID: 34311142
[TBL] [Abstract][Full Text] [Related]
7. Effects of Biologic Therapies on the Chance of COVID-19 Infection Among Rheumatoid Arthritis and Lupus Patients During the First Wave of the Pandemic.
Sahebari M; Mirfeizi Z; Hashemzadeh K; Salavati Nik E; Gholampoor Shamkani N
Arch Bone Jt Surg; 2022 Nov; 10(11):964-968. PubMed ID: 36561225
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
[TBL] [Abstract][Full Text] [Related]
9. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
[TBL] [Abstract][Full Text] [Related]
10. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
[TBL] [Abstract][Full Text] [Related]
11. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study.
Qian G; Wang X; Patel NJ; Kawano Y; Fu X; Cook CE; Vanni KMM; Kowalski EN; Banasiak EP; Bade KJ; Srivatsan S; Williams ZK; Todd DJ; Weinblatt ME; Wallace ZS; Sparks JA
Lancet Rheumatol; 2023 Mar; 5(3):e139-e150. PubMed ID: 36844970
[TBL] [Abstract][Full Text] [Related]
12. Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses.
Mehta P; Gasparyan AY; Zimba O; Kitas GD; Yessirkepov M
Clin Rheumatol; 2022 Dec; 41(12):3897-3913. PubMed ID: 36076125
[TBL] [Abstract][Full Text] [Related]
13. Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
Pang R; Zhao J; Gan Z; Hu Z; Xue X; Wu Y; Qiao Q; Zhong A; Xia X; Liao H; Wang Z; Zhang L
Aging (Albany NY); 2020 Dec; 12(23):23427-23435. PubMed ID: 33289698
[TBL] [Abstract][Full Text] [Related]
14. Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry.
Boteanu A; Leon L; Pérez Esteban S; Rabadán Rubio E; Pavía Pascual M; Bonilla G; Bonilla González-Laganá C; García Fernandez A; Recuero Diaz S; Ruiz Gutierrez L; Sanmartín Martínez JJ; de la Torre-Rubio N; Nuño L; Sánchez Pernaute O; Del Bosque I; Lojo Oliveira L; Rodríguez Heredia JM; Clemente D; Abasolo L; Bachiller-Corral J
Mod Rheumatol; 2023 Dec; 34(1):97-105. PubMed ID: 36516217
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases.
Alzahrani ZA; Alghamdi KA; Almaqati AS
Rheumatol Int; 2021 Jun; 41(6):1097-1103. PubMed ID: 33856543
[TBL] [Abstract][Full Text] [Related]
16. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evolution and levels of anti-S SARS-CoV-2 IgG in rheumatic disease and COVID-19].
Medina GA; Pino M; Geffner J; Perrotta NA; Barrios CV
Medicina (B Aires); 2021; 81(6):902-907. PubMed ID: 34875586
[TBL] [Abstract][Full Text] [Related]
18. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.
Pileggi GS; Ferreira GA; Reis APMG; Reis-Neto ET; Abreu MM; Albuquerque CP; Araújo NC; Bacchiega AB; Bianchi DV; Bica B; Bonfa ED; Borba EF; Brito DCSE; Duarte ÂLBP; Santo RCE; Fernandes PR; Guimarães MP; Gomes KWP; Kakehasi AM; Klumb EM; Lanna CCD; Marques CDL; Monticielo OA; Mota LMH; Munhoz GA; Paiva ES; Pereira HLA; Provenza JR; Ribeiro SLE; Junior LFR; Sampaio CSJC; Sampaio VS; Sato EI; Skare T; de Souza VA; Valim V; Lacerda MVG; Xavier RM; Pinheiro MM
Adv Rheumatol; 2021 Oct; 61(1):60. PubMed ID: 34620246
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease.
Walters HM; Mian Z; Thomas L; Cerise J; Eberhard BA; Pagano E; Gottlieb BS; Steigerwald K; Hui-Yuen JS
Rheumatology (Oxford); 2022 Jun; 61(SI2):SI112-SI119. PubMed ID: 34599820
[TBL] [Abstract][Full Text] [Related]
20. [Severe COVID-19 and outcomes in patients with rheumatic disease].
Galicia-Lucas UJ; Ramírez-Pérez AA
Rev Med Inst Mex Seguro Soc; 2021 Jun; 59(2):127-132. PubMed ID: 34231984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
